$49.8
Soleno Therapeutics is a biotechnology business based in the US. Soleno Therapeutics shares (SLNO) are listed on the NASDAQ and all prices are listed in US Dollars. Soleno Therapeutics employs 33 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Soleno Therapeutics stock
How to buy Soleno Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SLNO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Soleno Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Soleno Therapeutics stock price (NASDAQ: SLNO)
Use our graph to track the performance of SLNO stocks over time.Soleno Therapeutics shares at a glance
Latest market close | $49.80 |
---|---|
52-week range | $3.69 - $53.82 |
50-day moving average | $46.11 |
200-day moving average | $42.73 |
Wall St. target price | $70.29 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.83 |
Is it a good time to buy Soleno Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Soleno Therapeutics price performance over time
Historical closes compared with the close of $49.8 from 2024-09-04
1 week (2024-08-29) | 6.95% |
---|---|
1 month (2024-08-05) | 9.96% |
3 months (2024-06-05) | 11.78% |
6 months (2024-03-05) | 9.69% |
1 year (2023-09-05) | 1,085.71% |
---|---|
2 years (2022-09-01) | 2,123.21% |
3 years (2021-09-03) | 5,482.96% |
5 years (2019-09-05) | 2,666.67% |
Soleno Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -25.55% |
Return on equity TTM | -44.62% |
Profit margin | 0% |
Book value | $7.31 |
Market Capitalization | $1.9 billion |
TTM: trailing 12 months
Soleno Therapeutics share dividends
We're not expecting Soleno Therapeutics to pay a dividend over the next 12 months.
Have Soleno Therapeutics's shares ever split?
Soleno Therapeutics's shares were split on a 1:15 basis on 25 August 2022. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Soleno Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Soleno Therapeutics shares which in turn could have impacted Soleno Therapeutics's share price.
Soleno Therapeutics share price volatility
Over the last 12 months, Soleno Therapeutics's shares have ranged in value from as little as $3.69 up to $53.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Soleno Therapeutics's is -1.445. This would suggest that Soleno Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Soleno Therapeutics has bucked the trend.
Soleno Therapeutics overview
Soleno Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc.
Frequently asked questions
What percentage of Soleno Therapeutics is owned by insiders or institutions?Currently 3.722% of Soleno Therapeutics shares are held by insiders and 111.895% by institutions. How many people work for Soleno Therapeutics?
Latest data suggests 33 work at Soleno Therapeutics. When does the fiscal year end for Soleno Therapeutics?
Soleno Therapeutics's fiscal year ends in December. Where is Soleno Therapeutics based?
Soleno Therapeutics's address is: 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065 What is Soleno Therapeutics's ISIN number?
Soleno Therapeutics's international securities identification number is: US8342032005 What is Soleno Therapeutics's CUSIP number?
Soleno Therapeutics's Committee on Uniform Securities Identification Procedures number is: 834203101
More guides on Finder
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
6 stocks like Nvidia you need to consider
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Public vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Streitwise review
An online REIT with low fees, consistent dividends and a stable portfolio, but a brief track record.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question